Canada markets open in 1 hour 10 minutes

AZN Apr 2023 47.500 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.15000.0000 (0.00%)
As of 09:30AM EST. Market open.
Full screen
Previous Close0.1500
Open0.1500
Bid0.0000
Ask0.0000
Strike47.50
Expire Date2023-04-21
Day's Range0.1500 - 0.1500
Contract RangeN/A
Volume1
Open Interest81
  • Reuters

    UPDATE 1-Drugmakers prevail in dispute over U.S. discount drug program

    Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday. The ruling from a three-judge panel of the 3rd U.S. Circuit Court of Appeals based in Philadelphia is a victory for Sanofi SA, Novo Nordisk AS and AstraZeneca PLc . The companies had sued the U.S. Department of Health and Human Services (HHS) after it ordered them to stop restricting sales of discounted drugs to so-called contract pharmacies.

  • Reuters

    Drugmakers prevail in dispute over U.S. discount drug program

    (Reuters) -Drug manufacturers can limit healthcare providers' use of outside pharmacies for dispensing drugs under a federal drug discount program, a federal appeals court ruled Monday. The ruling from a three-judge panel of the 3rd U.S. Circuit Court of Appeals based in Philadelphia is a victory for Sanofi SA, Novo Nordisk AS and AstraZeneca PLc. The companies had sued the U.S. Department of Health and Human Services (HHS) after it ordered them to stop restricting sales of discounted drugs to so-called contract pharmacies.

  • Zacks

    Merck (MRK) to Report Q4 Earnings: What's in the Cards?

    Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda when the company reports Q4 earnings.